CH651045A5 - Process for preparing 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl) and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid esters - Google Patents

Process for preparing 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl) and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid esters Download PDF

Info

Publication number
CH651045A5
CH651045A5 CH4005/84A CH400584A CH651045A5 CH 651045 A5 CH651045 A5 CH 651045A5 CH 4005/84 A CH4005/84 A CH 4005/84A CH 400584 A CH400584 A CH 400584A CH 651045 A5 CH651045 A5 CH 651045A5
Authority
CH
Switzerland
Prior art keywords
carboxylic acid
dihydro
pyrrole
pyrrolo
formula
Prior art date
Application number
CH4005/84A
Other languages
German (de)
English (en)
Inventor
Joseph Martin Muchowski
Arthur F Kluge
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/771,283 external-priority patent/US4087539A/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of CH651045A5 publication Critical patent/CH651045A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH4005/84A 1976-07-14 1977-07-08 Process for preparing 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl) and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid esters CH651045A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70485776A 1976-07-14 1976-07-14
US05/771,283 US4087539A (en) 1976-07-14 1977-02-23 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof

Publications (1)

Publication Number Publication Date
CH651045A5 true CH651045A5 (en) 1985-08-30

Family

ID=27107392

Family Applications (2)

Application Number Title Priority Date Filing Date
CH4005/84A CH651045A5 (en) 1976-07-14 1977-07-08 Process for preparing 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl) and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid esters
CH848877A CH644861A5 (en) 1976-07-14 1977-07-08 Process for the preparation of 5-(2-furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH848877A CH644861A5 (en) 1976-07-14 1977-07-08 Process for the preparation of 5-(2-furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid derivatives

Country Status (26)

Country Link
JP (1) JPS539789A (cs)
AR (1) AR218631A1 (cs)
AU (1) AU513385B2 (cs)
CA (1) CA1100140A (cs)
CH (2) CH651045A5 (cs)
CS (1) CS208724B2 (cs)
DE (1) DE2731662A1 (cs)
DK (1) DK152652C (cs)
ES (2) ES460705A1 (cs)
FI (1) FI63407C (cs)
FR (1) FR2361396A1 (cs)
GB (1) GB1554076A (cs)
GR (1) GR61607B (cs)
HK (1) HK17581A (cs)
IE (1) IE45302B1 (cs)
IL (1) IL52492A (cs)
IT (1) IT1117314B (cs)
MY (1) MY8100371A (cs)
NL (1) NL7707652A (cs)
NO (1) NO147563C (cs)
NZ (1) NZ184611A (cs)
PL (1) PL111408B1 (cs)
PT (1) PT66779B (cs)
SE (1) SE434644B (cs)
SU (2) SU664566A3 (cs)
YU (2) YU43156B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4140698A (en) * 1977-07-25 1979-02-20 Syntex (Usa) Inc. 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles
US4353829A (en) * 1980-11-21 1982-10-12 Syntex (U.S.A.) Inc. Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters
US4511724A (en) * 1982-06-10 1985-04-16 Merck & Co., Inc. 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents
JPS5910589A (ja) * 1982-06-10 1984-01-20 メルク エンド カムパニー インコーポレーテツド 抗炎症剤および鎮痛剤として新規な5−(ピロ−ル−2−オイル)−1,2−ジヒドロ−3H−ピロロ〔1,2−a〕ピロ−ル誘導体
HU198927B (en) * 1987-01-14 1989-12-28 Richter Gedeon Vegyeszet Process for producing 1-/substituted aminomethyl/-octa-hydroindolo-(2,3-a)quinolizine derivatives, pharmaceutically applicable acid addition salts thereof, as well as pharmaceutical compositions comprising same
US4874871A (en) * 1987-03-25 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds

Also Published As

Publication number Publication date
PT66779A (fr) 1977-08-01
PT66779B (fr) 1978-12-18
SU664566A3 (ru) 1979-05-25
IE45302L (en) 1978-01-14
GB1554076A (en) 1979-10-17
JPS6254110B2 (cs) 1987-11-13
YU47683A (en) 1984-04-30
AU513385B2 (en) 1980-11-27
PL111408B1 (en) 1980-08-30
JPS539789A (en) 1978-01-28
AR218631A1 (es) 1980-06-30
YU43157B (en) 1989-04-30
IE45302B1 (en) 1982-07-28
CH644861A5 (en) 1984-08-31
CA1100140A (en) 1981-04-28
DK152652C (da) 1988-09-12
DK152652B (da) 1988-04-05
ES470213A1 (es) 1979-09-16
PL199602A1 (pl) 1979-01-29
DK307677A (da) 1978-01-15
DE2731662A1 (de) 1978-01-19
YU43156B (en) 1989-04-30
DE2731662C2 (cs) 1989-11-09
FR2361396B1 (cs) 1981-11-27
IL52492A0 (en) 1977-10-31
AU2697677A (en) 1979-01-18
CS208724B2 (en) 1981-09-15
NL7707652A (nl) 1978-01-17
YU47583A (en) 1984-06-30
ES460705A1 (es) 1979-10-01
FI63407B (fi) 1983-02-28
HK17581A (en) 1981-05-08
IL52492A (en) 1981-06-29
IT1117314B (it) 1986-02-17
NO772493L (no) 1978-01-17
FR2361396A1 (fr) 1978-03-10
GR61607B (en) 1978-12-02
FI63407C (fi) 1983-06-10
NO147563B (no) 1983-01-24
NO147563C (no) 1983-05-18
FI772154A (cs) 1978-01-15
SE7708142L (sv) 1978-01-15
SE434644B (sv) 1984-08-06
NZ184611A (en) 1979-03-28
MY8100371A (en) 1981-12-31
SU793400A3 (ru) 1980-12-30

Similar Documents

Publication Publication Date Title
DE2813373C2 (cs)
DE2731678C2 (cs)
DE2941869C2 (cs)
DE2705582A1 (de) Neue derivate des 1,2-dithiols, ihre herstellung und die sie enthaltenden zusammensetzungen
CH651045A5 (en) Process for preparing 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl) and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid esters
CH504416A (de) Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
DE2730832A1 (de) Thieno-(2,3-c)- und -(3,2-c)pyridine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0005559B1 (de) Phenylaminothiophenessigsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2735433C2 (de) Phenylnitromethanverbindungen und Verfahren zu deren Herstellung
DE2106038C3 (de) 2-Imidazolin-2-ylamino-benzo [b] thiophene und diese enthaltende pharmazeutische Präparate
AT364846B (de) Verfahren zur herstellung von neuen in stellung 5 substituierten 1,2-dihydro-3h-pyrrolo-(1,2-a) -pyrrol-1-carbonsaeuren und von deren einzelnen 1-saeureisomeren und d-saeureisomeren
DE2128887C3 (de) beta- geschweifte Klammer auf Benzo eckige Klammer auf b eckige Klammer zu thienyl- (3) geschweifte Klammer zu propionsäureaminoalkylester, Verfahren zu deren Herstellung und dieselben enthaltende Arzneimittel
AT390948B (de) Verfahren zur herstellung von neuen benzamid-derivaten
DE60107852T2 (de) Thienopyrrolidinone
CH644862A5 (en) 5-(2- and 3-furoyl)- and 5-(2- and 3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and their salts and esters
AT364845B (de) Verfahren zur herstellung von neuen in stellung 5 substituierten 1,2-dihydro-3h-pyrrolo-(1,2-a) -pyrrol-1-carbonsaeuren, von deren einzelnen 1-saeureisomeren und d-saeureisomeren und von deren pharmazeutisch unbedenklichen salzen
AT364844B (de) Verfahren zur herstellung von neuen 5-aroyl-1,2 -dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carbonsaeuren und ihren salzen
EP0045519B1 (de) Pyrrolo(3,4-d)(2)benzazepine, Zwischenprodukte und Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
AT369003B (de) Verfahren zur herstellung von neuen 5-aroyl-1,2dihydro-3h-pyrrolo(1,2-a)-pyrrol-1-carbons[ure
DE2211214A1 (de) Thiophendenvate und Verfahren zu deren Herstellung
DE3641907A1 (de) 4h-benzo(4,5)cyclohepta(1,2-b)thiophen derivate
CH641461A5 (en) 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives
DE2854341C2 (cs)
DE3504678A1 (de) Neue imidazolyl-oxyalkansaeuren und -thioalkansaeuren, ihre derivate und verfahren zu ihrer herstellung
DE2055264C3 (de) Thienyl(2) -essigsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
PL Patent ceased